Inhibikase Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.70

+0.12 (+7.59%)

As of Feb 8, 2:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +1,547.6% upside

Low Target $19.41

Average Target $28.01

High Target $39.32

Current Price $1.70

Current
$1.70

Target
$28.01

$19.41 $28.01 avg $39.32

Scenario Analysis

Bear Case

$19.41

1,041.8%

Low target

Base Case

$28.01

+1,547.6%

Avg target

Bull Case

$39.32

+2,212.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$33.35

-94.9% from high

52-Week Low

$22.87

+-92.6% from low

Target vs 52W High

$28.01

-16.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%